Arcadia Biosciences (RKDA) Tops Q2 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.71 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
• Apple’s big price hike seen as "an unprecedented push to protect margins"